MedTrace Logo

Ketum and Pain Tolerence

NCT03414099 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2021-04-28

No results posted yet for this study

Summary

The study aim is to evaluate potential analgesic properties of ketum using the cold pressor task.

Conditions

Interventions

DRUG

Ketum

Ketum (Mitragyna speciosa) is an indigenous plant of Southeast Asia reported to have medicinal value in traditional culture

DRUG

Placebo

Placebo drink matched for taste and appereance

Sponsors & Collaborators

  • Yale University

    collaborator OTHER

  • Universiti Sains Malaysia

    lead OTHER

Principal Investigators

  • Vicknasingam Kasinather, PhD · Director

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-23
Primary Completion
2021-12-30
Completion
2021-12-30

Countries

  • Malaysia

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03414099 on ClinicalTrials.gov